人工智能辅助息肉诊断可节省结肠镜检查成本:临床试验附加分析
该研究为一项临床试验的附加分析,纳入207例患者共250枚≤5mm直肠乙状结肠小息肉,评估AI辅助光学诊断对结肠镜检查成本的影响。AI鉴别肿瘤性息肉的灵敏度93.3%、特异度95.2%、阴性预测值95.2%。采用AI支持的「诊断后留置」策略相比「全部切除」策略,可降低平均结肠镜成本和年度报销总额。
要点
- AI辅助诊断后留置策略可减少不必要的息肉切除,降低结肠镜成本。
- AI鉴别小息肉灵敏度93.3%,特异度95.2%,阴性预测值95.2%。
核心结论
- 使用AI实现诊断后留置策略可大幅降低结肠镜检查成本。
研究设计与样本
- 本研究为一项临床试验的附加分析,纳入所有≤5mm直肠乙状结肠小息肉患者。
- 共纳入207例患者,250枚息肉(104枚肿瘤性,144枚非肿瘤性,2枚不确定)。
主要发现
- AI正确鉴别肿瘤性息肉的灵敏度为93.3%,特异度为95.2%,阴性预测值为95.2%。
- 在诊断后留置策略下,105枚息肉被切除,145枚被留置。
临床怎么用
- 对于≤5mm的直肠乙状结肠小息肉,可依据AI预测采用诊断后留置策略,避免不必要的切除,从而节省成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Artificial intelligence (AI) is being implemented in colonoscopy practice, but no study has investigated whether AI is cost saving. We aimed to quantify the cost reduction using AI as an aid in the optical diagnosis of colorectal polyps. METHODS: This study is an add-on analysis of a clinical trial that investigated the performance of AI for differentiating colorectal polyps (ie, neoplastic versus non-neoplastic). We included all patients with diminutive (≤5 mm) rectosigmoid polyps in the analyses. The average colonoscopy cost was compared for 2 scenarios: (1) a diagnose-and-leave strategy supported by the AI prediction (ie, diminutive rectosigmoid polyps were not removed when predicted as non-neoplastic), and (2) a resect-all-polyps strategy. Gross annual costs for colonoscopies were also calculated based on the number and reimbursement of colonoscopies conducted under public health insurances in 4 countries. RESULTS: Overall, 207 patients with 250 diminutive rectosigmoid polyps (104 neoplastic, 144 non-neoplastic, and 2 indeterminate) were included. AI correctly differentiated neoplastic polyps with 93.3% sensitivity, 95.2% specificity, and 95.2% negative predictive value. Thus, 105 polyps were removed and 145 were left under the diagnose-and-leave strategy, which was estimated to reduce the average colonoscopy cost and the gross annual reimbursement for colonoscopies by 18.9% and US$149.2 million in Japan, 6.9% and US$12.3 million in England, 7.6% and US$1.1 million in Norway, and 10.9% and US$85.2 million in the United States, respectively, compared with the resect-all-polyps strategy. CONCLUSIONS: The use of AI to enable the diagnose-and-leave strategy results in substantial cost reductions for colonoscopy.
引用
- Mori Y, Kudo SE, East JE, et al. Cost savings in colonoscopy with artificial intelligence-aided polyp diagnosis: an add-on analysis of a clinical trial (with video). Gastrointest Endosc. 2020. PMID: 32240683. doi:10.1016/j.gie.2020.03.3759
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。